Skip to main content
Premium Trial:

Request an Annual Quote

Discovery Genomics Loses Rights to U of Minnesota Patents, Vows to Soldier On

NEW YORK, Oct. 19 (GenomeWeb News) - The University of Minnesota has revoked several licenses to key patents granted to Discovery Genomics because the company did not meet a fund-raising threshold agreed to when the company was founded, GenomeWeb News has learned.

 

John Haaland, president and CEO of the five-year-old University of Minnesota spin-off, told GenomeWeb News that the university had informed his company that it would revoke the licenses to the patents, which cover a method for injecting DNA into a chromosome. According to a report last week in the Twin Cities Business Journal, the university decided to revoke the IP after DGI fell short of its fund-raising goal of $5 million. Instead, DGI has raised $2 million, according to the Business Journal.

 

Haaland declined to confirm or deny the financial details of the tech-transfer agreement for GenomeWeb News, but said that his company planned to use the funding to commercialize tests for hemophilia or orphan diseases, and that the company will "wrestle with IP issues as they come along."  

 

"We as a company are going forward," Haaland said.

 

Representatives from the University of Minnesota's office of business development confirmed that a letter had been sent informing DGI that the licenses were due to expire. The university declined to provide any further comment. 

 

OBD director Doug Johnson told the Business Journal that the university will seek new partners to commercialize the patented DNA injection method.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.